DJIA 16,880.36 -31.75 -0.19%
NASDAQ 4,462.90 20.20 0.45%
S&P 500 1,970.07 0.12 0.01%
market minute promo

Dendreon Corp (NASDAQ: DNDN)

2.10 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $2.10 $0.00 (0.00%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

DNDN $2.10 0.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.10
Previous Close $2.10
Daily Range $2.09 - $2.16
52-Week Range $1.81 - $5.38
Market Cap $335.9M
P/E Ratio -1.23
Dividend (Yield) $0.00 (0.0%)
Volume 1,199,738
Average Daily Volume 1,954,714
Current FY EPS -$0.79





Dendreon Corp (DNDN) Description

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer. Website:

News & Commentary Rss Feed

These 5 Cancer Immunotherapy Companies All Have 1 Thing in Common

Cancer immunotherapies are all the rage on Wall Street, but these five immunotherapy-focused companies all have one big thing in common.

3 Convincing Reasons To Buy Dendreon

Why You Should Buy Dendreon's Drop

August 29th Options Now Available For Dendreon

Stocks To Watch Today: NQ Mobile, CBS, Seadrill...

Morning Market Movers

Benzinga's Top #PreMarket Gainers

New Provenge Data: Why Deerfield Investments Acquired A More Than 5% Stake In May

What Does Dendreon Need To Succeed?

Dendreon (DNDN) Stock Has Huge Short Interest: Time to Cover? - Tale of the Tape

Long Or Short: Cancer Cures

See More DNDN News...

DNDN's Top Competitors

DNDN $2.10 (0.00%)
Current stock: DNDN
AMGN $130.01 (5.43%)
Current stock: AMGN
GILD $93.79 (0.86%)
Current stock: GILD
BIIB $344.52 (0.82%)
Current stock: BIIB